Literature DB >> 7217724

Intraventricular use of aminoglycosides in the treatment of gram-negative bacillary meningitis: conflicting views.

M N Swartz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7217724     DOI: 10.1093/infdis/143.2.293

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  9 in total

Review 1.  Cephalosporins in adult meningitis.

Authors:  T R Beam
Journal:  Bull N Y Acad Med       Date:  1984-05

Review 2.  The third generation cephalosporins.

Authors:  B Farber; R C Moellering
Journal:  Bull N Y Acad Med       Date:  1982-11

3.  Bacterial meningitis in Nottingham.

Authors:  P Ispahani
Journal:  J Hyg (Lond)       Date:  1983-10

4.  Effect of osmotic blood-brain barrier disruption on gentamicin penetration into the cerebrospinal fluid and brains of normal rabbits.

Authors:  L J Strausbaugh; G S Brinker
Journal:  Antimicrob Agents Chemother       Date:  1983-08       Impact factor: 5.191

5.  Analysis of eight cases of neonatal meningitis and sepsis due to Enterobacter sakazakii.

Authors:  H L Muytjens; H C Zanen; H J Sonderkamp; L A Kollée; I K Wachsmuth; J J Farmer
Journal:  J Clin Microbiol       Date:  1983-07       Impact factor: 5.948

Review 6.  Bacterial meningitis. Rational selection and use of antibacterial drugs.

Authors:  M Whitby; R Finch
Journal:  Drugs       Date:  1986-03       Impact factor: 9.546

7.  Intraventricular levels of amikacin after intravenous administration.

Authors:  R Yogev; W M Kolling
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

8.  Moxalactam therapy of bacterial meningitis in adults.

Authors:  M Uwaydah; N Tannir; H Kantarjian; M Osseiran; F Bal'a
Journal:  Antimicrob Agents Chemother       Date:  1983-02       Impact factor: 5.191

9.  Cefotaxime treatment of gram-negative enteric meningitis in infants and children.

Authors:  R F Jacobs
Journal:  Drugs       Date:  1988       Impact factor: 9.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.